Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for sleep quality and postoperative pain reduction
IRCT20230626058586N12Phase 2Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cannabidiol in postoperative pain and sleep disorder, sponsored by Tehran University of Medical Sciences. Primary endpoints: Sleep quality and Postoperative pain intensity. Started Feb 2026; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
postoperative painsleep disorder
Beyond the preview
Go deeper on IRCT20230626058586N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230626058586N12.